NASDAQ: XCBEX3 Acquisition Corp Ltd Stock
$10.01+0.00 (+0%)
Updated Sep 15, 2026
XCBE Price
$10.01
Fair Value Price
N/A
Market Cap
$281.53M
52 Week Low
$9.75
52 Week High
$10.05
P/E
100.1x
P/B
-60.92x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$2.69M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.27
Operating Cash Flow
-$414k
Beta
0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
XCBE Overview
X3 Acquisition Corp. Ltd. (XCBE) operates as a special purpose acquisition company (SPAC), primarily established to execute a strategic business combination. Its core objective is to merge with, acquire assets or stock from, reorganize, or engage in other similar corporate transactions with one or more existing enterprises. The entity was founded on July 31, 2025, and its principal offices are located in Minneapolis, Minnesota.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine XCBE's potential to beat the market
- XCBE doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
XCBE
RankedUnranked of 26
RankedUnranked of 26
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.90 | C | |
| $10.99 | C | |
| $13.30 | C |
Be the first to know about important XCBE news, forecast changes, insider trades & much more!
XCBE News
Overview
Due Diligence Score
–
Industry Average (8)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how XCBE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XCBE is poor value based on its earnings relative to its share price (100.1x), compared to the US market average (44.17x)
P/E vs Market Valuation
XCBE is poor value based on its earnings relative to its share price (100.1x), compared to the US Shell Companies industry average (15.32x)
P/E vs Industry Valuation
XCBE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more XCBE due diligence checks available for Premium users.
Valuation
XCBE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
100.1x
Industry
15.32x
Market
44.17x
XCBE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
XCBE is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
XCBE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-60.92x
Industry
114.72x
XCBE's financial health
Profit margin
Revenue
$0.0
Net Income
$1.8M
Profit Margin
0%
XCBE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$229.7M
Liabilities
$5.9M
Debt to equity
-1.27
XCBE's short-term assets ($1.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XCBE's long-term liabilities ($5.63M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XCBE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
XCBE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$277.0k
Investing
$0.0
Financing
$0.0
XCBE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
XCBE vs Shell Company Stocks
X3 Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.